ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,318.00
0.95%
다우존스 지수
39,069.59
0.01%
Bitcoin
68,561.68
0.07%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Apricus Biosciences, Inc. (APRI)

  7. Apricus Biosciences, Inc. (APRI) 뉴스

APRI

Apricus Biosciences, Inc. (APRI)

Apricus Biosciences, Inc.
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:APRI
일자시간출처헤드라인심볼기업
2019/01/2422:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APRIApricus Biosciences, Inc.
2019/01/2422:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APRIApricus Biosciences, Inc.
2019/01/2422:01GlobeNewswire Inc.Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage ...NASDAQ:APRIApricus Biosciences, Inc.
2019/01/2420:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APRIApricus Biosciences, Inc.
2019/01/2420:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APRIApricus Biosciences, Inc.
2019/01/1707:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APRIApricus Biosciences, Inc.
2019/01/1707:30Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:APRIApricus Biosciences, Inc.
2019/01/1521:00GlobeNewswire Inc.Apricus Biosciences Stockholders Approve Proposed Merger with Seelos Therapeutics, Inc.NASDAQ:APRIApricus Biosciences, Inc.
2019/01/0508:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:APRIApricus Biosciences, Inc.
2019/01/0507:58Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APRIApricus Biosciences, Inc.
2019/01/0502:08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APRIApricus Biosciences, Inc.
2018/12/2706:12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:APRIApricus Biosciences, Inc.
2018/12/1720:15Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:APRIApricus Biosciences, Inc.
2018/12/1720:15Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:APRIApricus Biosciences, Inc.
2018/12/1720:10Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:APRIApricus Biosciences, Inc.
2018/12/1506:49Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APRIApricus Biosciences, Inc.
2018/12/1506:47Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:APRIApricus Biosciences, Inc.
2018/12/1502:30GlobeNewswire Inc.Apricus Biosciences Adjourns Special Meeting of Stockholders to New DateNASDAQ:APRIApricus Biosciences, Inc.
2018/12/1021:00GlobeNewswire Inc.Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018NASDAQ:APRIApricus Biosciences, Inc.
2018/12/0622:08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:APRIApricus Biosciences, Inc.
2018/11/3022:02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:APRIApricus Biosciences, Inc.
2018/11/2120:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APRIApricus Biosciences, Inc.
2018/11/2107:23Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:APRIApricus Biosciences, Inc.
2018/11/2106:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APRIApricus Biosciences, Inc.
2018/11/1707:33Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:APRIApricus Biosciences, Inc.
2018/11/1706:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APRIApricus Biosciences, Inc.
2018/11/1706:15Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:APRIApricus Biosciences, Inc.
2018/11/0105:37Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APRIApricus Biosciences, Inc.
2018/11/0105:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APRIApricus Biosciences, Inc.
2018/11/0105:24GlobeNewswire Inc.Apricus Biosciences Provides Corporate Update and Third Quarter 2018 Financial ResultsNASDAQ:APRIApricus Biosciences, Inc.
 검색 관련기사 보기:NASDAQ:APRI

최근 히스토리

GATE
VRXUSDT
Verox
TSXV
GGL
GGL Resources
GATE
SNKUSDT
Snook
NASDAQ
HPK
HighPeak Energy
BIT
UB3565
UniCredit Bank
COIN
CCOINBTC
CREDITCOIN
OKEX
LEOETH
BIT
I05818
Banca Imi
COIN
KSOCEUR
KickSoccer Coin
BIT
UB2624
UniCredit Bank
EU
4533T
4533T
USOTC
COMS
COMSovereign (PK)
EU
A918T
A918T
EU
ALMOU
Moulinvest
LSE
XSX6
Xstoxeu600
COIN
2KEYUSD
TwoKeyEconomy
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유